Related Experiment Videos
Clindamycin-induced acute generalized exanthematous pustulosis.
R A Schwab1, P S Vogel, K E Warschaw
1Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
Cutis
|July 6, 2000
Summary
Acute generalized exanthematous pustulosis, a rare skin condition, is often caused by medications. This report details the first known case of this condition triggered by the antibiotic clindamycin.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Acute generalized exanthematous pustulosis (AGEP) is a rare, severe cutaneous adverse reaction.
- Drug exposure is the most frequent precipitating factor for AGEP.
Observation:
- This study reports the first documented case of AGEP induced by clindamycin.
- The patient presented with characteristic pustular eruptions following clindamycin administration.
Findings:
- Clindamycin, an antibiotic, can act as an etiological agent for acute generalized exanthematous pustulosis.
- The clinical presentation and resolution were consistent with established AGEP criteria.
Implications:
- Highlights the importance of considering clindamycin in the differential diagnosis of drug-induced AGEP.
- Contributes to the understanding of drug hypersensitivity reactions and expands the list of known causative agents for AGEP.